Planta Med 2006; 72 - P_054
DOI: 10.1055/s-2006-949854

Cucurbitacin R reduces delayed-type hypersensitivity reaction induced by dinitrofluorobenzene and sheep red blood cells in mice

JL Ríos 1, JM Escandell 1, M Cerdá-Nicolás 1, MC Recio 1
  • 1Departament de Farmacologia, Facultat de Farmacia, Universitat de València, Av. Vicent Andrés Estellés s/n, 46100 Burjassot, Spain; Departament de Patologia, Facultat de Medicina, Universitat de València, Av. Blasco Ibáñez 15, 46010 Valencia, Spain

The roots of Cayaponia tayuya (Vell.) Cogn. (Cucurbitaceae) are used in folk medicine as an anti-inflammatory and anti-allergic crude drug [1]. We previously reported its anti-inflammatory effect [2] and the anti-arthritic properties [3] of two cucurbitacins isolated from the chloroform extract. Now we tested the effects of cucurbitacin R (CCR) on different experimental models of systemic delayed-type hypersensitivity (DTH) in mice [3, 4].

CCR showed anti-allergic effects in two of the three models assayed. In the dinitrofluorobenzene (DNFB) model inhibited the ear oedema with a DI50 of 0.56mg/ear at 48h. In the sheep red blood cells (SRBC) model, the inhibition reached 64% (18h), 58% (24h) and 62% (48h). In the oxazolone-induced DTH there was not significant effect. In the histological studies of the DNFB-induced contact dermatitis, the CCR-treated group inhibited the oedema formation and the inflammatory cell infiltration, along with a reduction of the tissue damage. In the DTH-induced by SRBC, when compared with the non-treated group, the paws of the CCR-treated group (12.5mg/kg) present a mild inflammatory lesion and scarce mixture of inflammatory cells, and a reduction of tissue damage. In addition, CCR abolished the production of TNF-α and IL-1β in the paws of the CCR-treated group giving a 100% (TNF-α) and 90% (IL-1β) of inhibition.

Acknowledgements: J.M.E. is recipient of a grant from the Generalitat Valenciana. This work was supported by the Spanish Government (SAF2002–00723)

References: 1. Ríos, J.L. et al. (1990), Fitoterapia 61: 275–278. 2. Recio, M.C. et al. (2004), Planta Med. 70: 414–420. 3. Escandell, J. et al. (2006), Eur. J. Pharmacol. 532: 145–154. 4. Góngora, L. et al. (2000), Life Sci. 66: PL183.